Literature DB >> 18954701

The right ventricle in sepsis.

Chee M Chan1, James R Klinger.   

Abstract

Right ventricular dysfunction is common in sepsis and septic shock because of decreased myocardial contractility and elevated pulmonary vascular resistance despite a concomitant decrease in systemic vascular resistance. The mainstay of treatment for acute right heart failure includes treating the underlying cause of sepsis and reversing circulatory shock to maintain tissue perfusion and oxygen delivery. Decreasing pulmonary vascular resistance with selective pulmonary vasodilators is a reasonable approach to improving cardiac output in septic patients with right ventricular dysfunction. Treatment for right ventricular dysfunction in the setting of sepsis should concentrate on fluid repletion, monitoring for signs of RV overload, and correction of reversible causes of elevated pulmonary vascular resistance, such as hypoxia, acidosis, and lung hyperinflation.

Entities:  

Mesh:

Year:  2008        PMID: 18954701     DOI: 10.1016/j.ccm.2008.07.002

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  19 in total

Review 1.  Assessment and treatment of right ventricular failure.

Authors:  Marc A Simon
Journal:  Nat Rev Cardiol       Date:  2013-02-12       Impact factor: 32.419

Review 2.  [Treatment of acute and chronic right ventricular failure].

Authors:  T Kramm; S Guth; C B Wiedenroth; H A Ghofrani; E Mayer
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-05-30       Impact factor: 0.840

Review 3.  Right ventricular dysfunction during acute respiratory distress syndrome and veno-venous extracorporeal membrane oxygenation.

Authors:  Jeroen J H Bunge; Kadir Caliskan; Diederik Gommers; Dinis Reis Miranda
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

4.  Clinical spectrum, frequency, and significance of myocardial dysfunction in severe sepsis and septic shock.

Authors:  Juan N Pulido; Bekele Afessa; Mitsuru Masaki; Toshinori Yuasa; Shane Gillespie; Vitaly Herasevich; Daniel R Brown; Jae K Oh
Journal:  Mayo Clin Proc       Date:  2012-06-08       Impact factor: 7.616

5.  Prevalence and Outcomes of Pediatric In-Hospital Cardiac Arrest Associated With Pulmonary Hypertension.

Authors:  Ryan W Morgan; Alexis A Topjian; Yan Wang; Natalie J Atkin; Todd J Kilbaugh; Francis X McGowan; Robert A Berg; Laura Mercer-Rosa; Robert M Sutton; Adam S Himebauch
Journal:  Pediatr Crit Care Med       Date:  2020-04       Impact factor: 3.624

6.  Right-to-left ventricular end diastolic diameter ratio in severe sepsis and septic shock.

Authors:  Meghan M Cirulis; Jessica H Huston; Partha Sardar; Promporn Suksaranjit; Brent D Wilson; Nathan D Hatton; Theodore G Liou; John J Ryan
Journal:  J Crit Care       Date:  2018-09-24       Impact factor: 3.425

7.  Selective endothelin-A receptor blockade attenuates endotoxin-induced pulmonary hypertension and pulmonary vascular dysfunction.

Authors:  Brent M Toney; Amanda J Fisher; Marjorie Albrecht; Angelia D Lockett; Robert G Presson; Irina Petrache; Tim Lahm
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

8.  Right Ventricular Dysfunction in Early Sepsis and Septic Shock.

Authors:  Michael J Lanspa; Meghan M Cirulis; Brandon M Wiley; Troy D Olsen; Emily L Wilson; Sarah J Beesley; Samuel M Brown; Eliotte L Hirshberg; Colin K Grissom
Journal:  Chest       Date:  2020-10-14       Impact factor: 9.410

9.  Pulmonary Vasodilator Therapy in Shock-associated Cardiac Arrest.

Authors:  Ryan W Morgan; Robert M Sutton; Michael Karlsson; Andrew J Lautz; Constantine D Mavroudis; William P Landis; Yuxi Lin; Sejin Jeong; Nancy Craig; Vinay M Nadkarni; Todd J Kilbaugh; Robert A Berg
Journal:  Am J Respir Crit Care Med       Date:  2018-04-01       Impact factor: 30.528

10.  Evaluation of a model-based hemodynamic monitoring method in a porcine study of septic shock.

Authors:  James A Revie; David Stevenson; J Geoffrey Chase; Chris J Pretty; Bernard C Lambermont; Alexandre Ghuysen; Philippe Kolh; Geoffrey M Shaw; Thomas Desaive
Journal:  Comput Math Methods Med       Date:  2013-03-25       Impact factor: 2.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.